The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases

May 5, 2019 updated by: Jun Zhang

The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases In Male and Female Aged Over 18 Years In China

primary purpose:Evaluate the prevalence and incidence of HPV infection and related diseases in subjects.

Secondary purpose:Analyze risk factors of HPV infection and related diseases.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

4691

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangxi
      • Liuzhou, Guangxi, China
        • Liuzhou Center of disease prevention and control

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

5000 healthy volunteers will be recruited from the residents of Liuzhou through advertisment.

Description

Inclusion Criteria:

  • ages 18 to 55 years;
  • residents of the study site;
  • at least one sex partner;
  • Be able to understand and comply with the request of the protocol.

Exclusion Criteria:

  • pregnant;
  • has received HPV vaccines.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence and incidence of HPV infection
Time Frame: 1 year
Evaluate the prevalence and incidence of HPV infection and related diseases in subjects
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
risk factors of HPV infection and related diseases
Time Frame: 1 year
Analyze risk factors of HPV infection and related diseases.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Jun Zhang, Xiamen University
  • Principal Investigator: Ming-Qiang Li, Liuzhou Center of disease prevention and control

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

May 1, 2016

Study Registration Dates

First Submitted

July 9, 2014

First Submitted That Met QC Criteria

July 9, 2014

First Posted (Estimate)

July 11, 2014

Study Record Updates

Last Update Posted (Actual)

May 7, 2019

Last Update Submitted That Met QC Criteria

May 5, 2019

Last Verified

May 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Human Papillomavirus Infection

Subscribe